Insider trading

Period: 120 months Stock: DTIL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

107 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

107 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

107 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

107 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
107 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
107 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

107 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Nov 2023
Scimeca Dario General Counsel and Secretary
Sold on a plan
$6.41K 16,023 at 0.40
12.4%
Planned (10b5-1)
8 Jun 2023
Scimeca Dario General Counsel and Secretary
Sold on a plan
$10.02K 13,361 at 0.75
16.3%
Planned (10b5-1)
27 Apr 2023
List Alan Chief Medical Officer
Sold on a plan
$6.14K 7,771 at 0.79
12.1%
Planned (10b5-1)
22 Mar 2023
Amoroso Michael President and CEO
Sold on a plan
$38.54K 46,999 at 0.82
40.6%
Planned (10b5-1)
17 Mar 2023
Kelly John Alexander Chief Financial Officer
Bought
$17.20K 20,000 at 0.86
8.9%
Cluster · 3 buyers
6 Mar 2023
Scimeca Dario General Counsel and Secretary
Sold, plan not stated
$13.02K 12,172 at 1.07
19.6%
6 Mar 2023
List Alan Chief Medical Officer
Sold, plan not stated
$10.14K 9,473 at 1.07
19.9%
17 Oct 2022
Amoroso Michael President and CEO
Sold, plan not stated
$14.53K 11,006 at 1.32
45.5%
23 Sep 2022
Kelly John Alexander Chief Financial Officer
Bought
$10.09K 8,200 at 1.23
5.3%
Cluster · 3 buyers
22 Sep 2022
Kelly John Alexander Chief Financial Officer
Bought
$49.63K 37,037 at 1.34
31.5%
Cluster · 3 buyers
22 Jun 2022
Kelly John Alexander Chief Financial Officer
Bought
$50.68K 33,784 at 1.50
40.3%
Cluster · 3 buyers
8 Jun 2022
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$38.83K 18,849 at 2.06
0.5%
8 Jun 2022
Scimeca Dario General Counsel and Secretary
Sold, plan not stated
$20.26K 9,833 at 2.06
23.2%
27 Apr 2022
List Alan Chief Medical Officer
Sold, plan not stated
$16.33K 7,775 at 2.10
29.9%
17 Mar 2022
Kelly John Alexander Chief Financial Officer
Bought
$51.37K 16,677 at 3.08
85.5%
Cluster · 3 buyers
23 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$319.50K 30,000 at 10.65
21.2%
21 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$161.55K 15,000 at 10.77
11.9%
18 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$110.00K 10,000 at 11.00
8.2%
17 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$104.40K 10,000 at 10.44
8.2%
15 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$32.01K 2,858 at 11.20
2.5%
11 Jun 2021
THOMSON DAVID S. Chief Operating Officer
Sold, plan not stated
$345.60K 30,000 at 11.52
21.2%
17 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$187.60K 20,000 at 9.38
0.5%
14 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$88.70K 9,673 at 9.17
0.2%
13 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$88.51K 9,673 at 9.15
0.2%
13 May 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$86.69K 9,675 at 8.96
0.5%
12 May 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$84.37K 9,676 at 8.72
0.2%
10 May 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$80.40K 9,746 at 8.25
0.5%
7 May 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$83.49K 9,742 at 8.57
0.5%
19 Apr 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$84.08K 9,676 at 8.69
0.2%
16 Apr 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$85.53K 9,675 at 8.84
0.2%
15 Apr 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$84.76K 9,676 at 8.76
0.2%
12 Apr 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$84.45K 9,741 at 8.67
0.5%
9 Apr 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$86.37K 9,737 at 8.87
0.5%
8 Apr 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$87.62K 9,736 at 9.00
0.5%
18 Mar 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$107.09K 9,665 at 11.08
0.2%
17 Mar 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$105.54K 9,665 at 10.92
0.2%
16 Mar 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$115.64K 9,661 at 11.97
0.2%
12 Mar 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$110.33K 9,712 at 11.36
0.5%
11 Mar 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$110.51K 9,711 at 11.38
0.5%
10 Mar 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$114.48K 9,710 at 11.79
0.5%
22 Feb 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$116.31K 9,660 at 12.04
0.2%
19 Feb 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$111.61K 9,663 at 11.55
0.2%
18 Feb 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$118.69K 9,705 at 12.23
0.5%
18 Feb 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$83.83K 6,871 at 12.20
0.2%
17 Feb 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$119.18K 9,705 at 12.28
0.5%
16 Feb 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$128.97K 9,697 at 13.30
0.5%
29 Jan 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$78.94K 6,444 at 12.25
0.2%
28 Jan 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$77.13K 6,444 at 11.97
0.2%
27 Jan 2021
JANTZ DEREK Chief Scientific Officer
Sold, plan not stated
$82.32K 7,048 at 11.68
0.2%
26 Jan 2021
KANE MATTHEW R. President and CEO
Sold, plan not stated
$129.65K 9,697 at 13.37
0.5%
Showing 51–100 of 107. ← Newer Page 2 of 3 Older →